Hence, detection of lower levels of LINE-1 methylation may represent a novel biomarker that may support grading of IDH-mutant astrocytoma by indicating CNS WHO grade 4 behavior. This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).